格林美(002340.SZ)子公司獲得消毒產品生產企業衞生許可證
格隆匯2月23日丨格林美(002340.SZ)公佈,公司全資子公司格林美(江蘇)鈷業股份有限公司(“江蘇格林美”)於近日獲得江蘇省衞生健康委員會頒發的《消毒產品生產企業衞生許可證》。
面對新冠肺炎疫情期間消毒液處於供應緊張的狀態,公司全資子公司江蘇格林美積極響應國家號召,充分利用優勢的技術與人才,利用現有生產設備及現有生產工藝中的副產物緊急配置液體消毒劑捐贈給江蘇省泰州市,滿足其消殺消毒對消毒液的緊急需求。
近日,江蘇格林美取得了江蘇省衞生健康委員會頒發的液體消毒劑《消毒產品生產企業衞生許可證》。公司在保障主導產品正常生產經營的同時,將全力投入疫情防控急需消毒產品的生產,緩解當前全國消毒產品緊缺的現狀,用實際行動參與疫情防控阻擊戰,為全面打贏這場沒有硝煙的疫情防控人民戰爭貢獻力量,積極履行好上市公司社會責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.